ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 58 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,391 | -31.5% | 12,000 | 0.0% | 0.00% | – |
| Q4 2022 | $2,032 | +1.6% | 12,000 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | -66.7% | 12,000 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | -14.3% | 12,000 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | 0.0% | 12,000 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | -41.7% | 12,000 | 0.0% | 0.00% | – |
| Q3 2021 | $12,000 | -7.7% | 12,000 | 0.0% | 0.00% | – |
| Q2 2021 | $13,000 | +18.2% | 12,000 | 0.0% | 0.00% | – |
| Q1 2021 | $11,000 | +83.3% | 12,000 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | -33.3% | 12,000 | 0.0% | 0.00% | – |
| Q3 2020 | $9,000 | 0.0% | 12,000 | -25.0% | 0.00% | – |
| Q2 2020 | $9,000 | +50.0% | 16,000 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | -45.5% | 16,000 | 0.0% | 0.00% | – |
| Q4 2019 | $11,000 | 0.0% | 16,000 | 0.0% | 0.00% | – |
| Q3 2019 | $11,000 | -47.6% | 16,000 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $21,000 | -41.7% | 16,000 | -5.9% | 0.00% | 0.0% |
| Q1 2019 | $36,000 | -5.3% | 17,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $38,000 | – | 17,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| A.R.T. Advisors, LLC | 20,419 | $16,000 | 0.09% |
| Maven Securities LTD | 1,000,000 | $795,000 | 0.07% |
| Verdence Capital Advisors LLC | 88,382 | $69,000 | 0.02% |
| Hayden Royal, LLC | 26,000 | $20,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 55,752 | $44,000 | 0.01% |
| Qube Research & Technologies Ltd | 519,063 | $407,000 | 0.01% |
| Virtu Financial LLC | 39,683 | $31,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $18,000 | 0.01% |
| Jacobi Capital Management LLC | 25,000 | $20,000 | 0.00% |
| RVW Wealth, LLC | 19,000 | $15,000 | 0.00% |